Back

Akeso to present nearly 30 bispecific antibody studies at ESMO 2026

Verifying
  • Akeso will present nearly 30 bispecific antibody studies at the 2026 ESMO Congress.
  • Ivonescimab will appear in 12 presentations, including HARMONi-GI1 overall survival results.
  • The ESMO Congress will take place October 23–27, 2026, in Madrid.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.